Unresolved issues in implantable cardioverter-defibrillator therapy

被引：1

作者：

Mason, Pamela K. ^{[1
]}

DiMarco, John P. ^{[1
]}

机构：

[1] Univ Virginia Hlth Syst, Div Cardiovasc, Dept Internal Med, Charlottesville, VA 22908 USA

来源：

CARDIOLOGY CLINICS | 2008年 / 26卷 / 03期

关键词：

D O I：

10.1016/j.ccl.2008.03.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Over the last 15 years, a series of well-designed randomized clinical trials has clearly demonstrated that implantable cardioverter-defibrillator (ICD) therapy reduces mortality in select high-risk populations. Despite the widespread acceptance of ICD therapy, many questions related to its optimal use remain. This article discusses several key issues now confronting clinicians.

引用

页码：433 / +

页数：8

共 33 条

[1] Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004 [J].

Al-Khatib, SM ;

Sanders, GD ;

Mark, DB ;

Lee, KL ;

Bardy, GH ;

Bigger, JT ;

Buxton, AE ;

Connolly, S ;

Kadish, A ;

Moss, A ;

Feldman, AM ;

Ellenbogen, KA ;

Singh, S ;

Califf, RM .

AMERICAN HEART JOURNAL, 2005, 149 (06) :1020-1034

[2] Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].

Bardy, GH ;

Lee, KL ;

Mark, DB ;

Poole, JE ;

Packer, DL ;

Boineau, R ;

Domanski, M ;

Troutman, C ;

Anderson, J ;

Johnson, G ;

McNulty, SE ;

Clapp-Channing, N ;

Davidson-Ray, LD ;

Fraulo, ES ;

Fishbein, DP ;

Luceri, RM ;

Ip, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237

[3] Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].

Bristow, MR ;

Saxon, LA ;

Boehmer, J ;

Krueger, S ;

Kass, DA ;

De Marco, T ;

Carson, P ;

DiCarlo, L ;

DeMets, D ;

White, BG ;

DeVries, DW ;

Feldman, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150

[4]

Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P123

[5] The effect of cardiac resynchronization on morbidity and mortality in heart failure [J].

Cleland, JGF ;

Daubert, J ;

Erdmann, E ;

Freemantle, N ;

Gras, D ;

Kappenberger, L ;

Tavazzi, L ;

Cleland, JGF ;

Daubert, JC ;

Erdmann, E ;

Gras, D ;

Kappenberger, L ;

Klein, W ;

Tavazzi, L ;

Poole-Wilson, PA ;

Rydén, L ;

Wedel, H ;

Wellens, HJJ ;

Uretsky, B ;

Thygesen, K ;

Böcker, D ;

Marijianowski, MMH ;

Freemantle, N ;

Calvert, MJ ;

Christ, G ;

Fruhwald, F ;

Hofmann, R ;

Krypta, A ;

Leisch, F ;

Pacher, R ;

Rauscha, F ;

Tavernier, R ;

Thomsen, PEB ;

Boesgaard, S ;

Eiskjær, H ;

Esperen, GT ;

Haarbo, J ;

Hagemann, A ;

Korup, E ;

Moller, M ;

Mortensen, P ;

Sogaard, P ;

Vesterlund, T ;

Huikuri, H ;

Niemelä, KI ;

Toivonen, L ;

Bauer, F ;

Cohen-Solal, A ;

Crocq, C ;

Djiane, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) :1539-1549

[6] Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] [J].

Cleland, John G. F. ;

Daubert, Jean-Claude ;

Erdmann, Erland ;

Freemantle, Nick ;

Gras, Daniel ;

Kappenberger, Lukas ;

Tavazzi, Luigi .

EUROPEAN HEART JOURNAL, 2006, 27 (16) :1928-1932

[7] Changing incidence,of out-of-hospital ventricular fibrillation. 1980-2000 [J].

Cobb, LA ;

Fahrenbruch, CE ;

Olsufka, M ;

Copass, MK .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (23) :3008-3013

[8]

*DHHS CMS, 2005, CMS MAN SYST PUB MED

[9] Variations between clinical trial participants and medicare beneficiaries in evidence used for medicare national coverage decisions [J].

Dhruva, Sanket S. ;

Redberg, Rita F. .

ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (02) :136-140

[10] Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator [J].

Dorian, P ;

Borggrefe, M ;

Al-Khalidi, HR ;

Hohnloser, SH ;

Brum, JM ;

Tatla, DS ;

Brachmann, J ;

Myerburg, RJ ;

Cannom, DS ;

van der Laan, M ;

Holroyde, MJ ;

Singer, I .

CIRCULATION, 2004, 110 (24) :3646-3654

← 1 2 3 4 →